| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/08/2012 | CN102342953A Methods and compositions for the treatment of gastrointestinal disorders |
| 02/08/2012 | CN102342946A Application of bile acid peiminine ester and its derivative in preparation of antitumor medicines |
| 02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
| 02/08/2012 | CN102342931A Injectable parenteral medicinal preparation of temozolomide and preparation method thereof |
| 02/08/2012 | CN102342928A Medicinal application of arctigenin |
| 02/08/2012 | CN102342919A Preparation method for 5-fluorouracil/PLGA (Polylactic-co-Glycolic Acid) medicine carrying microspheres |
| 02/08/2012 | CN102342916A Lansoprazole enteric-coated capsule prescription and preparation method thereof |
| 02/08/2012 | CN101926895B 一种中药组合物及其制备方法和应用 Chinese medicinal composition and its preparation method and application |
| 02/08/2012 | CN101863823B 吲哚二酮类化合物及其扩环衍生物、制备方法及应用 Indole ring expansion diketones and derivatives, preparation method and application |
| 02/08/2012 | CN101810860B 一种有抗肿瘤协同增效作用的药物组合物 A kind of synergistic anti-tumor pharmaceutical composition |
| 02/08/2012 | CN101736008B 一种制备基因工程N-乙酰化胸腺素α1的方法 A process for preparing N- acetylated genetic engineering methods thymosin α1 |
| 02/08/2012 | CN101732232B 一种多烯紫杉醇纳米粒组合物 A multi-docetaxel nanoparticle compositions |
| 02/08/2012 | CN101716349B 一种用于栓塞治疗和止痛的药物组合物及其制备方法 An embolization and analgesic pharmaceutical composition and its preparation method |
| 02/08/2012 | CN101711871B 银纳米链网状材料及制备方法和在制备治疗肿瘤药物中的应用 Nano silver chain mesh material and preparation method and application in the manufacture of a medicament for the treatment of cancer |
| 02/08/2012 | CN101708270B 一种解毒抗癌中药组合物 One kind of detoxification cancer medicine composition |
| 02/08/2012 | CN101691568B 一种可食性固定化活性益生菌的生产方法 One kind of edible immobilized active probiotic production methods |
| 02/08/2012 | CN101658639B 一种铁皮石斛多糖含片及其制备方法 One kind of Dendrobium polysaccharide tablets and its preparation method |
| 02/08/2012 | CN101648920B 用作组蛋白去乙酰酶抑制剂的三氟甲基酮类化合物及其用途 Used as a histone deacetylase inhibitor trifluoromethyl ketone compounds and their uses |
| 02/08/2012 | CN101613391B 3-(d-吡喃葡萄糖基)噻唑衍生物及其制备方法和应用 3- (d- glucopyranosyl) thiazole derivatives and preparation method and application |
| 02/08/2012 | CN101585841B 愈创木内酯类倍半萜二聚体及其制备方法与制药用途 Yuchuang Kiuchi sesquiterpene lactones dimers and preparation method and pharmaceutical use |
| 02/08/2012 | CN101573337B 作为抗肿瘤剂的5、6或7-取代-3-(杂)芳基-异喹啉胺衍生物 5, 6 or 7 as an anti-tumor agent is a substituted 3- (hetero) aryl - isoquinoline derivatives of the amine |
| 02/08/2012 | CN101497600B 2,4,5-三取代-1,3-二硫戊环、其合成方法、其应用 2,4,5-trisubstituted-1,3-dithiolane, their synthesis, their application |
| 02/08/2012 | CN101428034B 具有增效减毒特点的抗肿瘤组合药物 Have a synergistic anti-tumor drug combination attenuated characteristics |
| 02/08/2012 | CN101406451B 一种冬凌草甲素静脉乳及其制备方法 One kind Oridonin vein milk and its preparation method |
| 02/08/2012 | CN101370510B 包含肽的抗癌剂 Peptides containing the anticancer agent |
| 02/08/2012 | CN101204402B 一种水蛭的真空冷冻干燥工艺 One kind of vacuum freeze-drying process leech |
| 02/08/2012 | CN101189003B Hdac抑制剂的药物制剂 Inhibitor pharmaceutical preparations Hdac |
| 02/08/2012 | CN101176755B 槲皮素-7-o-葡萄糖甙在柘木或其制剂检测方法中的应用 -7-O- glucose quercetin glycosides used in Tsugeki detection method of preparation thereof |
| 02/08/2012 | CN101120960B 南蛇藤茎总萜提取物及其制备方法及用途 Celastrus stems total terpene extract and its preparation method and uses |
| 02/08/2012 | CN101113159B 预防与治疗肺癌细胞侵袭转移的反义寡核苷酸的结构及用途 Prevention and treatment of lung cancer cell invasion and metastasis antisense oligonucleotide structure and purpose |
| 02/07/2012 | US8110683 Piperidinyl compounds that selectively bind integrins |
| 02/07/2012 | US8110657 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/07/2012 | US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof |
| 02/07/2012 | US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 02/07/2012 | US8110587 Aryl ureas as kinase inhibitors |
| 02/07/2012 | US8110574 Derivatives of 4-aminopiperidine and their use as a medicament |
| 02/07/2012 | US8110568 Inhibitors of IAP |
| 02/07/2012 | US8110550 HDAC inhibitors and hormone targeted drugs for the treatment of cancer |
| 02/07/2012 | US8110544 RasGAP derived peptide for selectively killing cancer cells |
| 02/07/2012 | US8110543 Anti-invasive and anti-angiogenic compositions |
| 02/07/2012 | US8110542 Methods of expressing proteins with disulfide bridges |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110370 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer |
| 02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
| 02/07/2012 | US8110179 A water-soluble, cyclodextrin-containing linear polymer having bioactive moieties to attached a drug(s) or modified drug to the polymer covalently; cleavage under biological conditions to release the bioactive moieties; sustained release; side effect reduction; stability; nontoxic; drug polymer conjugate |
| 02/07/2012 | CA2632433C Methods for preparing macrocyclic analogs and intermediates for preparing same |
| 02/07/2012 | CA2510006C Compositions comprising a combination of diphenyl urea impdh inhibitors and apoptosis-inducing anti-cancer agents |
| 02/07/2012 | CA2497898C Liquid stable composition of oxazaphosphorine with mesna |
| 02/07/2012 | CA2497640C Medical device having hydration inhibitor |
| 02/07/2012 | CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 02/07/2012 | CA2471044C Benzimidazole derivatives and their use as gnrh antagonists |
| 02/07/2012 | CA2466536C Transdermal transport of compounds |
| 02/07/2012 | CA2461243C Radioactive arsenic-containing compounds and their uses in the treatment of tumors |
| 02/07/2012 | CA2452923C Peptide-based compounds for targeting integrin receptors |
| 02/07/2012 | CA2434747C Camptothecin derivatives |
| 02/07/2012 | CA2386463C April receptor (bcma) and uses thereof |
| 02/07/2012 | CA2383850C Prevention and treatment of mycoplasma-associated diseases |
| 02/07/2012 | CA2333147C Cancer treatment methods using antibodies to aminophospholipids |
| 02/07/2012 | CA2328989C Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 02/07/2012 | CA2273196C Isolated mammalian monocyte cell genes; related reagents |
| 02/07/2012 | CA2264484C Human plasma hyaluronidase |
| 02/02/2012 | WO2012016133A2 Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers |
| 02/02/2012 | WO2012016050A2 Chemoradiotherapy for kras-mutant colorectal cancer |
| 02/02/2012 | WO2012016001A1 Cyclic amine azaheterocyclic carboxamides |
| 02/02/2012 | WO2012015986A2 Substituted dioxopiperidinyl phtalimide derivatives |
| 02/02/2012 | WO2012015937A2 Parp1 targeted therapy |
| 02/02/2012 | WO2012015914A2 Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics |
| 02/02/2012 | WO2012015820A1 Composition and method for photodynamic disinfection |
| 02/02/2012 | WO2012015775A2 Sirna targeting vegfa and methods for treatment in vivo |
| 02/02/2012 | WO2012015696A1 Thymic stromal lymphopoietin (tslp) and ox40 ligand in cancer |
| 02/02/2012 | WO2012015677A1 6- (1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5- |
| 02/02/2012 | WO2012015486A1 Pairing processes for preparing reactive cytotoxic t cells |
| 02/02/2012 | WO2012015008A1 Anti-tumor agent |
| 02/02/2012 | WO2012014994A1 Naphthalene derivative |
| 02/02/2012 | WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes |
| 02/02/2012 | WO2012014936A1 Cancer stem cell differentiation inducer |
| 02/02/2012 | WO2012014890A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 02/02/2012 | WO2012014492A1 Immunity inducer |
| 02/02/2012 | WO2012014221A1 Substituted 4-(4-fluoro-3-(piperazine-1- carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase- 1 inhibitors |
| 02/02/2012 | WO2012014149A1 N-methylformamide solvate of dasatinib |
| 02/02/2012 | WO2012014147A1 Anticancer derivatives, preparation thereof and therapeutic use thereof |
| 02/02/2012 | WO2012014046A2 Supramolecular aggregates as drug carriers on cell expressing receptors for branched neurotensin |
| 02/02/2012 | WO2012013821A1 Inhibition of dicer function for treatment of cancer |
| 02/02/2012 | WO2012013816A1 Compounds and methods for treating neoplasia |
| 02/02/2012 | WO2012013727A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 02/02/2012 | WO2012013725A1 Vinylogous chalcone derivatives and their medical use |
| 02/02/2012 | WO2012013557A1 Isoxazolo-quinazolines as modulators of protein kinase activity |
| 02/02/2012 | WO2012013495A1 Pharmaceutical and/or dietary compositions based on short chain fatty acids |
| 02/02/2012 | WO2012013282A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 02/02/2012 | WO2012013249A1 Dentin matrix protein 1 (dmp1) for use in pharmaceutical compositions |
| 02/02/2012 | WO2012013147A1 Acenaphtho heterocyclic compound and application thereof |
| 02/02/2012 | WO2012013117A1 Pharmaceutical composition of temozolomide comprising vitamin c or vitamin c derivative and preparation method thereof |
| 02/02/2012 | WO2012013116A1 Pharmaceutical composition of temozolomide comprising amino acid stabilizer and preparation method thereof |
| 02/02/2012 | WO2012013111A1 Angiogenesis-inhibiting peptide and application thereof |
| 02/02/2012 | WO2012013110A1 Polypeptide having angiogenesis-inhibiting activity |
| 02/02/2012 | WO2012013016A1 Curcumalactone derivatives with antitumor activity and preparation process thereof |
| 02/02/2012 | WO2012012941A1 Bcl-2 family protein inhibitors, their cyclodextrin inclusion compounds, complexes, and uses in manufacture of bcl-2 family protein inhibitors thereof |
| 02/02/2012 | WO2012012874A1 Immunogenic anti-inflammatory compositions |
| 02/02/2012 | WO2011149354A8 Mirnas involved in the blood brain barrier function |
| 02/02/2012 | WO2011148083A4 Peptide for use as a medicament, in particular for the treatment of cancer |